Cargando…

Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer

Deregulated E2F transcription factor activity occurs in the vast majority of human tumors and has been solidly implicated in disturbances of cell cycle control, proliferation, and apoptosis. Aberrant E2F regulatory activity is often caused by impairment of control through pRB function, but little is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilke, Sven, Schwentner, Raphaela, Yang, Fan, Kauer, Maximilian, Jug, Gunhild, Walker, Robert L., Davis, Sean, Zhu, Yuelin J., Pineda, Marbin, Meltzer, Paul S., Kovar, Heinrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814880/ https://www.ncbi.nlm.nih.gov/pubmed/23940108 http://dx.doi.org/10.1101/gr.151340.112

Ejemplares similares

A Molecular Function Map of Ewing's Sarcoma
por: Kauer, Maximilian, et al.
Publicado: (2009)

EWS-FLI1 employs an E2F switch to drive target gene expression
por: Schwentner, Raphaela, et al.
Publicado: (2015)

The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma
por: Schwentner, Raphaela, et al.
Publicado: (2016)

EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells
por: Mutz, Cornelia N., et al.
Publicado: (2017)

YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
por: Bierbaumer, Lisa, et al.
Publicado: (2021)

Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma
por: Aryee, D N T, et al.
Publicado: (2013)

Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers
por: Tsafou, Kalliopi, et al.
Publicado: (2018)

Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma
por: Niedan, S, et al.
Publicado: (2014)

Downstream EWS/FLI1 - upstream Ewing's sarcoma
por: Kovar, Heinrich
Publicado: (2010)

Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
por: Kowalewski, Ashley A., et al.
Publicado: (2011)

Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
por: Herrero-Martin, David, et al.
Publicado: (2011)

Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response
por: Gorthi, Aparna, et al.
Publicado: (2018)

EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma
por: Katschnig, A M, et al.
Publicado: (2017)

FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
por: Christensen, Laura, et al.
Publicado: (2013)

Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis
por: Aryee, Dave N. T., et al.
Publicado: (2022)

The First European Interdisciplinary Ewing Sarcoma Research Summit
por: Kovar, Heinrich, et al.
Publicado: (2012)

CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010)

Progress in the Molecular Biology of Ewing Tumors
por: Kovar, Heinrich
Publicado: (1998)

EWS‐FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway
por: Mutz, Cornelia N., et al.
Publicado: (2016)

Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
por: Orth, Martin F., et al.
Publicado: (2022)

One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma
por: Flores, Guillermo, et al.
Publicado: (2021)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
por: Zöllner, Stefan K., et al.
Publicado: (2021)

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
por: Parrish, Janet K., et al.
Publicado: (2018)

NKAP functions as an oncogene in Ewing sarcoma cells partly through the AKT signaling pathway
por: Li, Feng, et al.
Publicado: (2019)

Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
por: Marchetto, Aruna, et al.
Publicado: (2020)

C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells
por: Gardiner, Jamie D., et al.
Publicado: (2017)

Ewing Sarcoma of the Posterior Fossa in an Adolescent Girl
por: Stark, Andreas M., et al.
Publicado: (2014)

Replicon: a software to accurately predict DNA replication timing in metazoan cells
por: Gindin, Yevgeniy, et al.
Publicado: (2014)

Ewing's sarcoma of zygoma
por: Deshingkar, SA, et al.
Publicado: (2009)

Ewing's sarcoma of the mandible
por: Rao, B. H. Sripathi, et al.
Publicado: (2011)

Chemotherapy in Ewing’s sarcoma
por: Jain, Sandeep, et al.
Publicado: (2010)

The Biology of Ewing Sarcoma
por: Ross, Keir A., et al.
Publicado: (2013)

Ewing's Sarcoma of the Finger
por: Gökalp, Mehmet Ata, et al.
Publicado: (2014)

Ewing's Sarcoma of the Calcaneum
por: Sherif, P Ajmal, et al.
Publicado: (2017)

Paratesticular Ewing's sarcoma
por: Koshevarova, Victoria, et al.
Publicado: (2023)

ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma
por: Srivastava, Swati, et al.
Publicado: (2019)

Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity
por: Ullah, Asad, et al.
Publicado: (2021)

Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes
por: Niemeyer, Brian F., et al.
Publicado: (2015)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vo84kre654sun4js4d1fmaod3p